These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23536208)

  • 1. Polysaccharide-lecithin reverse micelles with enzyme-degradable triglyceride shell for overcoming tumor multidrug resistance.
    Su CW; Chen SY; Liu DM
    Chem Commun (Camb); 2013 May; 49(36):3772-4. PubMed ID: 23536208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration In Vitro and In Vivo.
    Su CW; Chiang MY; Lin YL; Tsai NM; Chen YP; Li WM; Hsu CH; Chen SY
    J Biomed Nanotechnol; 2016 May; 12(5):962-72. PubMed ID: 27305818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatin.
    Xu YY; Du YZ; Yuan H; Liu LN; Niu YP; Hu FQ
    J Drug Target; 2011 Jun; 19(5):344-53. PubMed ID: 20854014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
    Hafner A; Lovrić J; Romić MD; Juretić M; Pepić I; Cetina-Čižmek B; Filipović-Grčić J
    Eur J Pharm Sci; 2015 Jul; 75():142-50. PubMed ID: 25869457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake.
    Barbieri S; Sonvico F; Como C; Colombo G; Zani F; Buttini F; Bettini R; Rossi A; Colombo P
    J Control Release; 2013 May; 167(3):276-83. PubMed ID: 23428841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lecithin/chitosan nanoparticles for transdermal delivery of melatonin.
    Hafner A; Lovrić J; Pepić I; Filipović-Grčić J
    J Microencapsul; 2011; 28(8):807-15. PubMed ID: 22117177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin.
    Senyiğit T; Sonvico F; Barbieri S; Ozer O; Santi P; Colombo P
    J Control Release; 2010 Mar; 142(3):368-73. PubMed ID: 19932722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.
    Wang YC; Wang F; Sun TM; Wang J
    Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells.
    Du YZ; Wang L; Yuan H; Hu FQ
    Int J Biol Macromol; 2011 Jan; 48(1):215-22. PubMed ID: 21093477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity.
    Xiangyang X; Ling L; Jianping Z; Shiyue L; Jie Y; Xiaojin Y; Jinsheng R
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):222-8. PubMed ID: 17254755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance.
    Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z
    Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin loading fucoidan acetate nanoparticles for immune and chemotherapy in cancer treatment.
    Lee KW; Jeong D; Na K
    Carbohydr Polym; 2013 May; 94(2):850-6. PubMed ID: 23544642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
    Hu FQ; Wu XL; Du YZ; You J; Yuan H
    Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size Changeable Nanocarriers with Nuclear Targeting for Effectively Overcoming Multidrug Resistance in Cancer Therapy.
    Guo X; Wei X; Jing Y; Zhou S
    Adv Mater; 2015 Nov; 27(41):6450-6. PubMed ID: 26401989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro.
    Wang Y; Chen L; Ding Y; Yan W
    Int J Pharm; 2012 Jan; 422(1-2):409-17. PubMed ID: 22037443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
    Hu FQ; Liu LN; Du YZ; Yuan H
    Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells.
    Kim KR; Kim DR; Lee T; Yhee JY; Kim BS; Kwon IC; Ahn DR
    Chem Commun (Camb); 2013 Mar; 49(20):2010-2. PubMed ID: 23380739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.